Genetic modifiers of degeneration in the cathepsin D deficient Drosophila model for neuronal ceroid lipofuscinosis

Neurobiology of Disease

Volumn 36, Issue 3, 2009, Pages 488-493

  Kuronen, Mervi ^a,b   Talvitie, Minnamari ^a   Lehesjoki, Anna Elina ^a,b   Myllykangas, Liisa ^a,b  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cathepsin D; Drosophila; Genetic modifier; Neurodegeneration

Indexed keywords

CATHEPSIN D; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DROSOPHILA; ENDOCYTOSIS; LIPID METABOLISM; NERVE DEGENERATION; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPATHOLOGY; NONHUMAN; OXIDATION; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RETINA;

EID: 70350377798     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.09.001     Document Type: Article

References (48)

1. Acharya U., and Acharya J.K. Enzymes of sphingolipid metabolism in Drosophila melanogaster. Cell. Mol. Life Sci. 62 (2005) 128-142
2. Acharya U., Patel S., Koundakjian E., Nagashima K., Han X., and Acharya J.K. Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science 299 (2003) 1740-1743
3. Awano T., Katz M.L., O'Brien D.P., Taylor J.F., Evans J., Khan S., Sohar I., Lobel P., and Johnson G.S. A mutation in the cathepsin D gene (CTSD) in American bulldogs with neuronal ceroid lipofuscinosis. Mol. Genet. Metab. 87 (2006) 341-348
4. Benedict J.W., Sommers C.A., and Pearce D.A. Progressive oxidative damage in the central nervous system of a murine model for juvenile Batten disease. J. Neurosci Res. 85 (2007) 2882-2891
5. Benes P., Vetvicka V., and Fusek M. Cathepsin D-many functions of one aspartic protease. Crit. Rev. Oncol. Hematol. 68 (2008) 12-28
6. Bilen J., and Bonini N.M. Drosophila as a model for human neurodegenerative disease. Annu. Rev. Genet. 39 (2005) 153-171
7. Bourbon H.M., Gonzy-Treboul G., Peronnet F., Alin M.F., Ardourel C., Benassayag C., Cribbs D., Deutsch J., Ferrer P., Haenlin M., Lepesant J.A., Noselli S., and Vincent A. A P-insertion screen identifying novel X-linked essential genes in Drosophila. Mech. Dev. 110 (2002) 71-83
8. Buff H., Smith A.C., and Korey C.A. Genetic modifiers of Drosophila palmitoyl-protein thioesterase 1-induced degeneration. Genetics 176 (2007) 209-220
9. Chang H.C., Newmyer S.L., Hull M.J., Ebersold M., Schmid S.L., and Mellman I. Hsc70 is required for endocytosis and clathrin function in Drosophila. J. Cell Biol. 159 (2002) 477-487
10. Cullen V., Lindfors M., Ng J., Paetau A., Swinton E., Kolodziej P., Boston H., Saftig P., Woulfe J., Feany M.B., Myllykangas L., Schlossmacher M.G., and Tyynela J. Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo. Mol. Brain 2 (2009) 5
11. Duran M.C., Martin-Ventura J.L., Mohammed S., Barderas M.G., Blanco-Colio L.M., Mas S., Moral V., Ortega L., Tunon J., Jensen O.N., Vivanco F., and Egido J. Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. Eur. J. Pharmacol. 562 (2007) 119-129
12. Felbor U., Kessler B., Mothes W., Goebel H.H., Ploegh H.L., Bronson R.T., and Olsen B.R. Neuronal loss and brain atrophy in mice lacking cathepsins B and L. Proc. Natl. Acad. Sci. U S A. 99 (2002) 7883-7888
13. Fritchie K., Siintola E., Armao D., Lehesjoki A.E., Marino T., Powell C., Tennison M., Booker J.M., Koch S., Partanen S., Suzuki K., Tyynela J., and Thorne L.B. Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10). Acta Neuropathol. 117 (2009) 201-208
14. Gopalakrishnan M.M., Grosch H.W., Locatelli-Hoops S., Werth N., Smolenova E., Nettersheim M., Sandhoff K., and Hasilik A. Purified recombinant human prosaposin forms oligomers that bind procathepsin D and affect its autoactivation. Biochem. J. 383 (2004) 507-515
15. Haidar B., Kiss R.S., Sarov-Blat L., Brunet R., Harder C., McPherson R., and Marcel Y.L. Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid efflux. J. Biol. Chem. 281 (2006) 39971-39981
16. Halliwell B. Proteasomal dysfunction: a common feature of neurodegenerative diseases? Implications for the environmental origins of neurodegeneration. Antioxid. Redox Signal. 8 (2006) 2007-2019
17. Hennig K.M., Colombani J., and Neufeld T.P. TOR coordinates bulk and targeted endocytosis in the Drosophila melanogaster fat body to regulate cell growth. J. Cell Biol. 173 (2006) 963-974
18. Hermansson M., Kakela R., Berghall M., Lehesjoki A.E., Somerharju P., and Lahtinen U. Mass spectrometric analysis reveals changes in phospholipid, neutral sphingolipid and sulfatide molecular species in progressive epilepsy with mental retardation, EPMR, brain: a case study. J. Neurochem. 95 (2005) 609-617
19. Hiraiwa M., Martin B.M., Kishimoto Y., Conner G.E., Tsuji S., and O'Brien J.S. Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside. Arch. Biochem. Biophys. 341 (1997) 17-24
20. Jabs S., Quitsch A., Kakela R., Koch B., Tyynela J., Brade H., Glatzel M., Walkley S., Saftig P., Vanier M.T., and Braulke T. Accumulation of bis(monoacylglycero)phosphate and gangliosides in mouse models of neuronal ceroid lipofuscinosis. J. Neurochem. 106 (2008) 1415-1425
21. Joensuu T., Kuronen M., Alakurtti K., Tegelberg S., Hakala P., Aalto A., Huopaniemi L., Aula N., Michellucci R., Eriksson K., and Lehesjoki A.E. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients. Eur. J. Hum. Genet. 15 (2007) 185-193
22. Kakela R., Somerharju P., and Tyynela J. Analysis of phospholipid molecular species in brains from patients with infantile and juvenile neuronal-ceroid lipofuscinosis using liquid chromatography-electrospray ionization mass spectrometry. J. Neurochem. 84 (2003) 1051-1065
23. Koike M., Nakanishi H., Saftig P., Ezaki J., Isahara K., Ohsawa Y., Schulz-Schaeffer W., Watanabe T., Waguri S., Kametaka S., Shibata M., Yamamoto K., Kominami E., Peters C., von Figura K., and Uchiyama Y. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J. Neurosci. 20 (2000) 6898-6906
24. Koike M., Shibata M., Ohsawa Y., Nakanishi H., Koga T., Kametaka S., Waguri S., Momoi T., Kominami E., Peters C., Figura K., Saftig P., and Uchiyama Y. Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol. Cell. Neurosci. 22 (2003) 146-161
25. Koike M., Shibata M., Waguri S., Yoshimura K., Tanida I., Kominami E., Gotow T., Peters C., von Figura K., Mizushima N., Saftig P., and Uchiyama Y. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am. J. Pathol. 167 (2005) 1713-1728
26. Korey C.A., and MacDonald M.E. An over-expression system for characterizing Ppt1 function in Drosophila. BMC Neurosci. 4 (2003) 30
27. Kretzschmar D. Swiss cheese et allii, some of the first neurodegenerative mutants isolated in Drosophila. J. Neurogenet. 23 (2009) 34-41
28. Laurent-Matha V., Lucas A., Huttler S., Sandhoff K., Garcia M., and Rochefort H. Procathepsin D interacts with prosaposin in cancer cells but its internalization is not mediated by LDL receptor-related protein. Exp. Cell Res. 277 (2002) 210-219
29. Ma X.M., and Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev., Mol. Cell Biol. 10 (2009) 307-318
30. Martin D.E., and Hall M.N. The expanding TOR signaling network. Curr. Opin. Cell Biol. 17 (2005) 158-166
31. Mayer M.P., and Bukau B. Hsp70 chaperones: cellular functions and molecular mechanism. Cell. Mol. Life Sci. 62 (2005) 670-684
32. Missirlis F., Phillips J.P., and Jackle H. Cooperative action of antioxidant defense systems in Drosophila. Curr. Biol. 11 (2001) 1272-1277
33. Missirlis F., Ulschmid J.K., Hirosawa-Takamori M., Grönke S., Schäfer U., Becker K., Phillips J.P., and Jäckle H. Mitochondrial and cytoplasmic thioredoxin reductase variants encoded by a single Drosophila gene are both essential for viability. J. Biol. Chem. 277 (2002) 11521-11526
34. Myllykangas L., Tyynela J., Page-McCaw A., Rubin G.M., Haltia M.J., and Feany M.B. Cathepsin D-deficient Drosophila recapitulate the key features of neuronal ceroid lipofuscinoses. Neurobiol. Dis. 19 (2005) 194-199
35. Nakanishi H., Zhang J., Koike M., Nishioku T., Okamoto Y., Kominami E., von Figura K., Peters C., Yamamoto K., Saftig P., and Uchiyama Y. Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J. Neurosci. 21 (2001) 7526-7533
36. Partanen S., Haapanen A., Kielar C., Pontikis C., Alexander N., Inkinen T., Saftig P., Gillingwater T.H., Cooper J.D., and Tyynela J. Synaptic changes in the thalamocortical system of cathepsin D-deficient mice: a model of human congenital neuronal ceroid-lipofuscinosis. J. Neuropathol. Exp. Neurol. 67 (2008) 16-29
37. Praefcke G.J., and McMahon H.T. The dynamin superfamily: universal membrane tubulation and fission molecules?. Nat. Rev., Mol. Cell Biol. 5 (2004) 133-147
38. Qiao L., Hamamichi S., Caldwell K.A., Caldwell G.A., Yacoubian T.A., Wilson S., Xie Z.L., Speake L.D., Parks R., Crabtree D., Liang Q., Crimmins S., Schneider L., Uchiyama Y., Iwatsubo T., Zhou Y., Peng L., Lu Y., Standaert D.G., Walls K.C., Shacka J.J., Roth K.A., and Zhang J. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain 1 (2008) 17
39. Salvioli R., Ricci-Vitiani L., Tatti M., Scarpa S., De Maria R., and Vaccaro A.M. The secretion and maturation of prosaposin and procathepsin D are blocked in embryonic neural progenitor cells. Biochim. Biophys. Acta 1783 (2008) 1480-1489
40. Shacka J.J., and Roth K.A. Cathepsin D deficiency and NCL/Batten disease: there's more to death than apoptosis. Autophagy 3 (2007) 474-476
41. Shacka J.J., Klocke B.J., Young C., Shibata M., Olney J.W., Uchiyama Y., Saftig P., and Roth K.A. Cathepsin D deficiency induces persistent neurodegeneration in the absence of bax-dependent apoptosis. J. Neurosci. 27 (2007) 2081-2090
42. Siintola E., Partanen S., Stromme P., Haapanen A., Haltia M., Maehlen J., Lehesjoki A.E., and Tyynela J. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129 (2006) 1438-1445
43. Steinfeld R., Reinhardt K., Schreiber K., Hillebrand M., Kraetzner R., Bruck W., Saftig P., and Gartner J. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am. J. Hum. Genet. 78 (2006) 988-998
44. Tschape J.A., Hammerschmied C., Muhlig-Versen M., Athenstaedt K., Daum G., and Kretzschmar D. The neurodegeneration mutant lochrig interferes with cholesterol homeostasis and Appl processing. EMBO J. 21 (2002) 6367-6376
45. Tyynela J., Sohar I., Sleat D.E., Gin R.M., Donnelly R.J., Baumann M., Haltia M., and Lobel P. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J. 19 (2000) 2786-2792
46. Urrutia R., Henley J.R., Cook T., and McNiven M.A. The dynamins: Redundant or distinct functions for an expanding family of related GTPases?. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 377-384
47. Walls K.C., Klocke B.J., Saftig P., Shibata M., Uchiyama Y., Roth K.A., and Shacka J.J. Altered regulation of phosphatidylinositol 3-kinase signaling in cathepsin D-deficient brain. Autophagy 3 (2007) 222-229
48. Zhu Y., and Conner G.E. Intermolecular association of lysosomal protein precursors during biosynthesis. J. Biol. Chem. 269 (1994) 3846-3851